APCN&KSN 2024
http://www.apcn2024.org/
Welcome to Asian Pacific Congress of Nephrology 2024 x 44th Annual Meeting of the Korean Society of Nephrology
June 13(Thu) – 16(Sun), 2024 ㅣ Coex, Seoul, Korea
❗ Promotional Video: https://www.youtube.com/watch?v=Egsew7TA0Wc
❗ APCN&KSN 2024 SNS
https://www.facebook.com/profile.php?id=100089257417801
https://www.instagram.com/ksn_meeting/
Tweets by ksnmeeting
The Korean Society of Nephrology
Fresenius Kabi is a global health care company that specialises in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients.
With our corporate philosophy of “caring for life”, we are committed to putting essential medicines and technologies in the hands of people who help patients and finding the best answers to the challenges they face.
Fresenius Kabi New Zealand
Ph: 0800 144 892
www.fresenius-kabi.com/nz
Alexion, Astra Zeneca Rare Diseases, has been a leader in rare diseases for 30 years. Alexion is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialisation of life-changing medicines. We continue to deepen our understanding of rare disease, which began with our pioneering work in complement biology. This knowledge allows us to innovate and evolve into new areas, where there is great unmet need and opportunity to help patients and families fully live their best lives.
https://alexion.com/worldwide/australia
CSL Vifor in Australia is a leader in iron deficiency and has a rapidly growing presence in nephrology. We are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease. Our focus in nephrology is supported by our expertise in iron deficiency therapy, helping to support a broad range of patients in need.
CSL Vifor in Australia is proud to sponsor local medical education and invest in research and development to help patients lead better, healthier lives.
Pharmacor, established in Australia in 2007, is a dynamic contributor in the complex field of generic medicine. We excel in detailed fixed-dose formulations, supplying a diverse range of prescription and OTC medications to pharmacies and hospitals nationwide. Our ambition is to lead the Australian generics market in a sustainable and environmentally conscious manner. Key to this is our strategy of introducing first-to-market generics, which bolsters competition while also enhancing the sustainability of the healthcare system by controlling costs. To achieve these goals, we are fostering strong partnerships with research and development allies who are equally committed to sustainability.
In collaboration with Alkem Laboratories, we’re striving towards a future of sustainable and equitable healthcare. Our shared vision is to ensure all Australians have rapid access to affordable generic medicines, while we simultaneously uphold our commitment to environmental stewardship. Our strength is epitomised by our TGA & FDA approved research and manufacturing facilities, which operate with a keen focus on environmental responsibility.
We insist on using premium ingredients sourced from certified manufacturers, ensuring that our medicine is safe, effective, and produced with minimal environmental footprint. Our mission to provide affordable alternatives to nephrology patients aims to ease the financial strain on hospital budgets while ensuring medical outcomes are equivalent to those provided by brand-name drugs.
At Pharmacor, we are pioneering a future that unites affordability, quality, and environmental sustainability. We are committed to not only delivering medicine, but also to fostering a healthier and greener future for our healthcare system.
For more information, please visit:
https://www.pharmacor.com.au
Brochures
Mycophenolate
Generic Vs Branded Medicines
Pharmacor Portfolio
Video
This site uses cookies. Find out more about cookies and how you can refuse them.
